Effectiveness and safety analysis of rituximab in 146 Indian pemphigus patients: A retrospective single-center review of up to 68 months follow-up
Conclusion: This study reinforces the beneficial role of rituximab in pemphigus. Pemphigus foliaceus patients required a higher total cumulative dose of prednisolone over a longer time to achieve remission and the remission lasted longer than that in pemphigus vulgaris.
Source: Indian Journal of Dermatology, Venereology and Leprology - Category: Dermatology Authors: Dipankar De Anuradha Bishnoi Sanjeev Handa Tanmay Mahapatra Rahul Mahajan Source Type: research
More News: Allergy & Immunology | Arthritis | Corticosteroid Therapy | Dermatology | India Health | Men | Pemphigus | Prednisolone | Rheumatoid Arthritis | Rheumatology | Rituxan | Skin | Study